| International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ... Journal of thoracic oncology 6 (2), 244-285, 2011 | 5975 | 2011 |
| Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer GV Scagliotti, P Parikh, J Von Pawel, B Biesma, J Vansteenkiste, ... Journal of clinical oncology 26 (21), 3543-3551, 2008 | 4297 | 2008 |
| First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ... New England Journal of Medicine 371 (23), 2167-2177, 2014 | 3600 | 2014 |
| Lung cancer: current therapies and new targeted treatments FR Hirsch, GV Scagliotti, JL Mulshine, R Kwon, WJ Curran, YL Wu, ... The Lancet 389 (10066), 299-311, 2017 | 2875 | 2017 |
| Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group JP Pignon, H Tribodet, GV Scagliotti, JY Douillard, FA Shepherd, ... Database of Abstracts of Reviews of Effects (DARE): Quality-Assessed Reviews …, 2008 | 2841 | 2008 |
| Gefitinib in combination with paclitaxel and carboplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 2 RS Herbst, G Giaccone, JH Schiller, RB Natale, V Miller, C Manegold, ... Journal of Clinical Oncology 22 (5), 785-794, 2004 | 2338 | 2004 |
| Gefitinib in combination with gemcitabine and cisplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 1 G Giaccone, RS Herbst, C Manegold, G Scagliotti, R Rosell, V Miller, ... Journal of Clinical Oncology 22 (5), 777-784, 2004 | 2308 | 2004 |
| Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer … DH Henry, L Costa, F Goldwasser, V Hirsh, V Hungria, J Prausova, ... J Clin Oncol 29 (9), 1125-1132, 2011 | 1415 | 2011 |
| Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer GV Scagliotti, F De Marinis, M Rinaldi, L Crino, C Gridelli, S Ricci, ... Journal of clinical oncology 20 (21), 4285-4291, 2002 | 1226 | 2002 |
| The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies G Scagliotti, N Hanna, F Fossella, K Sugarman, J Blatter, P Peterson, ... The oncologist 14 (3), 253-263, 2009 | 908 | 2009 |
| Prevalence of adrenal incidentaloma in a contemporary computerized tomography series S Bovio, A Cataldi, G Reimondo, P Sperone, S Novello, A Berruti, ... Journal of endocrinological investigation 29, 298-302, 2006 | 863 | 2006 |
| Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non–small-cell lung cancer GV Scagliotti, R Fossati, V Torri, L Crino, G Giaccone, G Silvano, ... Journal of the National Cancer Institute 95 (19), 1453-1461, 2003 | 819 | 2003 |
| The 2021 WHO classification of lung tumors: impact of advances since 2015 AG Nicholson, MS Tsao, MB Beasley, AC Borczuk, E Brambilla, ... Journal of Thoracic Oncology 17 (3), 362-387, 2022 | 711 | 2022 |
| Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data NSCLC Meta-analyses Collaborative Group The Lancet 375 (9722), 1267-1277, 2010 | 701 | 2010 |
| Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ... Journal of thoracic oncology 13 (9), 1248-1268, 2018 | 634 | 2018 |
| Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open … AT Shaw, TM Kim, L Crinò, C Gridelli, K Kiura, G Liu, S Novello, A Bearz, ... The Lancet Oncology 18 (7), 874-886, 2017 | 574 | 2017 |
| Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy … P Maione, F Perrone, C Gallo, L Manzione, FV Piantedosi, S Barbera, ... Journal of Clinical Oncology 23, 6865-6872, 2005 | 566 | 2005 |
| Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase P Ceppi, M Volante, S Saviozzi, I Rapa, S Novello, A Cambieri, ... Cancer 107 (7), 1589-1596, 2006 | 539 | 2006 |
| Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer G Scagliotti, S Novello, J von Pawel, M Reck, JR Pereira, M Thomas, ... J Clin Oncol 28 (11), 1835-1842, 2010 | 515 | 2010 |
| ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine P Ceppi, M Volante, S Novello, I Rapa, KD Danenberg, PV Danenberg, ... Annals of Oncology 17 (12), 1818-1825, 2006 | 500 | 2006 |
